HOME >> MEDICINE >> NEWS
Molecular marker may help identify pancreatic cancer, and possibly predict survival time

Preliminary research suggests that the expression pattern of microRNA (a short RNA molecule) may be useful in differentiating between chronic pancreatitis and pancreatic cancer and may be able to distinguish long and short term survival time for patients with pancreatic cancer, according to an article in the May 2 issue of JAMA.

Pancreatic cancer is a lethal disease, with the annual deaths nearly equaling the incidence of 33,000 in the United States, according to background information in the article. In humans, aberrant expression of miRNAs contributes to carcinogenesis by promoting the expression of proto-oncogenes (a normal gene that has the potential to become an oncogene [a gene that can cause a cell to become malignant]) or by inhibiting the expression of tumor suppressor genes. MicroRNAs (miRNAs) are small noncoding RNAs (ribonucleic acids; nucleic acids are present in all living cells). The role of miRNAs in ductal adenocarcinoma (malignant tumor) of the pancreas is not clear.

Mark Bloomston, M.D., of Ohio State University, Columbus, Ohio, and colleagues conducted a series of experiments to identify the pattern of miRNA expression in pancreatic adenocarcinoma to attempt to differentiate pancreatic cancer from benign pancreatic tissue and any differences in survival associated with certain miRNA expression. Study specimens were obtained at a National Cancer Institute-designated comprehensive cancer center from patients with ductal adenocarcinoma of the pancreas (n = 65) or chronic pancreatitis (n = 42) (January 2000-December 2005). RNA was harvested from resected pancreatic cancers and benign adjacent pancreatic tissue as well as from chronic pancreatitis specimens and subsequent miRNA was analyzed to identify associations with certain tissue types and prognosis.

"We have identified-we believe for the first time-a global expression pattern of miRNAs that can differentiate ductal adenocarcinomas of the pancreas from normal panc
'"/>

Contact: David Crawford
614-293-3737
JAMA and Archives Journals
1-May-2007


Page: 1 2 3

Related medicine news :

1. Elsevier launches Molecular Oncology
2. Molecular differences between early and advanced melanomas could provide new drug targets
3. Molecular structure reveals how botulinum toxin attaches to nerve cells
4. Molecular medicine comes to the rescue
5. Molecular switch may turn off immune cells that target HIV
6. Molecular imaging may lead to earlier diagnosis of childhood respiratory virus
7. The Molecular Profiling Institute, Inc. and IBM advance technology
8. Molecular Profiling Institute secures $7.5 million in Series B funding
9. Molecular studies in cancer of the colon
10. Molecular ballet unravels, links proteins so cell can direct own movement
11. Molecular testing in patients with rare cancer predicts response to Gleevec

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... LAS VEGAS (PRWEB) , ... July 17, 2019 ... ... an innovative thought leader offering fresh, insightful, honest perspectives on today’s issues affecting ... Workshop from Noon, 12 p.m. PST on Saturday, July 20, 2019. , ...
(Date:7/17/2019)... ... July 17, 2019 , ... It took just several small ... Martinez, MD, to relieve pressure on the nerves under Amber Walck’s scalp, and suddenly ... woman turned 30 last year, her debilitating headaches began without warning. About 39 ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... A new ... Journal of the American Medical Association (JAMA), shows for the first time ... deaths in the state. Sepsis is the body’s extreme response to infection. It kills ...
(Date:7/13/2019)... ... July 14, 2019 , ... Dr. Rupa Jolly, dentist ... The New Orleans Advocate's A-List of Most Influential New Orleanians in 2019. She joins ... and other newsmakers that have made an impact on the New Orleans community. , ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... CUBIO Innovation Center , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, ... 2019. , The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, ...
Breaking Medicine News(10 mins):
(Date:7/19/2019)... (PRWEB) , ... July 19, 2019 , ... ... (deoxyhemoglobin vasodilator) device. D’OXYVA is a novel non-invasive transdermal (over-the-skin) technology, which is ... the depth and breadth of the clinical evidence obtained by Circularity over the ...
(Date:7/19/2019)... ... , ... Today, Licensed Therapist and Founder/Operator of The Missing Peace Center for ... Peace with the opening of their newest facility, The Missing Peace Center for the ... , The Missing Peace Center for the Brain exclusively offers Neurofeedback as the sole ...
(Date:7/19/2019)... ANA, Calif. (PRWEB) , ... July 19, 2019 , ... ... (SQF) Certification. This means that the facilities was audited by the Safe Quality Food ... the requirements for the SQF Food Safety Code for Manufacturing, Edition 8. , The ...
Breaking Medicine Technology:
Cached News: